Work

Is diabetes still a compelling indication for renin-angiotensin-aldosterone system inhibitors?

Year: 2020

Type: letter

Abstract: TO THE EDITOR : The recent review by Momoniat et al, “ACE inhibitors and ARBs: Managing potassium and renal function,” provides a thorough overview of these important medication classes.[1][1] The authors state, “In general, a renin-angiotensin-aldosterone system inhibitor is recommended if

Source: Cleveland Clinic Journal of Medicine

DOI: 10.3949/ccjm.87c.01001

Authors: Robert Fakheri, Sripal Bangalore, Franz Messerli

Institutions: Weill Cornell Medicine, NYU Langone Health, University of Bern, Jagiellonian University, Icahn School of Medicine at Mount Sinai

Language: English

Topic: Renin-Angiotensin System Studies

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W3001604041

Cites: 10

Cited by:

Related to: 10